These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8630633)

  • 1. A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis.
    Huskisson EC; Ghozlan R; Kurthen R; Degner FL; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():29-34. PubMed ID: 8630633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis.
    Wojtulewski JA; Schattenkirchner M; Barceló P; Le Loët X; Bevis PJ; Bluhmki E; Distel M
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():22-8. PubMed ID: 8630632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritis.
    Reginster JY; Distel M; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():17-21. PubMed ID: 8630631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment.
    Bevis PJ; Bird HA; Lapham G
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():56-60. PubMed ID: 8630639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of meloxicam in patients with rheumatoid arthritis.
    Lemmel EM; Bolten W; Burgos-Vargas R; Platt P; Nissilä M; Sahlberg D; Björneboe O; Baumgartner H; Valat JP; Franchimont P; Bluhmki E; Hanft G; Distel M
    J Rheumatol; 1997 Feb; 24(2):282-90. PubMed ID: 9034984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of clinical trials and benefit/risk ratio of meloxicam.
    Barner A
    Scand J Rheumatol Suppl; 1996; 102():29-37. PubMed ID: 8628979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of meloxicam: a global analysis of clinical trials.
    Distel M; Mueller C; Bluhmki E; Fries J
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():68-77. PubMed ID: 8630641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.
    Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Dequeker J; Isomäki H; Littlejohn G; Mau J; Papazoglou S
    Br J Rheumatol; 1998 Sep; 37(9):937-45. PubMed ID: 9783757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip.
    Lindén B; Distel M; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():35-8. PubMed ID: 8630634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, randomized, placebo-controlled study of efficacy and tolerance of meloxicam treatment in patients with osteoarthritis of the knee.
    Lund B; Distel M; Bluhmki E
    Scand J Rheumatol; 1998; 27(1):32-7. PubMed ID: 9506875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of multiple administration of intramuscular meloxicam: a comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis.
    Ghozlan PR; Bernhardt M; Vélicitat P; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():51-5. PubMed ID: 8630638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac.
    Furst DE; Kolba KS; Fleischmann R; Silverfield J; Greenwald M; Roth S; Hall DB; Roszko PJ;
    J Rheumatol; 2002 Mar; 29(3):436-46. PubMed ID: 11908554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium.
    Hosie J; Distel M; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():39-43. PubMed ID: 8630635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
    Layton D; Hughes K; Harris S; Shakir SA
    Rheumatology (Oxford); 2003 Nov; 42(11):1332-41. PubMed ID: 12810929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients.
    Combe B; Vélicitat P; Garzón N; Bluhmki E
    Inflamm Res; 2001 Mar; 50 Suppl 1():S10-6. PubMed ID: 11339515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meloxicam in rheumatoid arthritis.
    Ahmed M; Khanna D; Furst DE
    Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):739-51. PubMed ID: 16863437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis.
    Foeldvari I; Burgos-Vargas R; Thon A; Tuerck D
    J Rheumatol; 2002 May; 29(5):1079-83. PubMed ID: 12022326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized trial to compare meloxicam 15 mg with diclofenac 100 mg in the treatment of osteoarthritis of the knee.
    Goei Thè HS; Lund B; Distel MR; Bluhmki E
    Osteoarthritis Cartilage; 1997 Jul; 5(4):283-8. PubMed ID: 9404473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meloxicam (Mobic): a review of its pharmacological and clinical profile].
    Ogino K; Saito K; Osugi T; Satoh H
    Nihon Yakurigaku Zasshi; 2002 Dec; 120(6):391-7. PubMed ID: 12528470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study.
    Altman R; Hochberg M; Gibofsky A; Jaros M; Young C
    Curr Med Res Opin; 2015 Dec; 31(12):2331-43. PubMed ID: 26503347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.